Sutro Biopharma
STRO
STRO
118 hedge funds and large institutions have $398M invested in Sutro Biopharma in 2022 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 57 increasing their positions, 28 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.97% less ownership
Funds ownership: 9.66% → 8.69% (-0.97%)
37% less call options, than puts
Call options by funds: $714K | Put options by funds: $1.14M
Holders
118
Holding in Top 10
1
Calls
$714K
Puts
$1.14M
Top Buyers
| 1 | +$14.6M | |
| 2 | +$8.27M | |
| 3 | +$6.88M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.8M |
| 5 |
SCM
Suvretta Capital Management
New York
|
+$4.4M |
Top Sellers
| 1 | -$15M | |
| 2 | -$9.44M | |
| 3 | -$8.16M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$7.68M |
| 5 |
Holocene Advisors
New York
|
-$3.97M |